summary slide.png (114.21 kB)
Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
media
posted on 2021-06-28, 13:29 authored by Adis journals on behalf of:, Wendy Y. Cheng, Sujata P. Sarda, Nikita Mody-Patel, Sangeeta Krishnan, Mihran Yenikomshian, Malena Mahendran, Dominique Lejeune, Louise H. Yu, Mei Sheng DuhArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
